Estrogen Patch Shortage: What to Do If You Can’t Get Your Usual HRT

If your pharmacy just told you your estradiol patch is unavailable, you're not imagining a supply problem, and you're not alone. Pharmacies across the country are reporting the same message, especially for twice-weekly estradiol patches such as Vivelle-Dot and its generic equivalents. Availability of specific brands and doses has been shifting week to week, so what's out of stock today may be different at your next refill.

This isn't a single pharmacy's inventory hiccup. Pharmacists are tracking it, and women are clearly having trouble filling prescriptions they've relied on for years. It's worth understanding both what's driving it and what your actual options are if your usual prescription isn't available this month.

One thing to know up front: the picture is a little contradictory depending on who you ask. The American Society of Health-System Pharmacists (ASHP) lists estradiol patches as in short supply, and patients and providers are reporting real difficulty at the counter. The FDA, on the other hand, has not added the patch to its official shortage list, because by its criteria supply has technically kept up with demand, though the FDA commissioner has said manufacturers are keeping up "but barely." In other words, whether or not it meets the formal definition, the day-to-day experience for many women has been a shortage.

Why is there an estrogen patch shortage right now?

The clearest driver is demand: more women are using estrogen therapy than ever, and production hasn't kept pace.

The numbers are striking. The number of women ages 45 to 54 prescribed estrogen-based therapies increased by about 184% between 2018 and early 2026, and prescriptions rose roughly another 20% between July 2025 and February 2026 alone, according to Truveta prescription data reported by NBC News. Much of that growth traces back to a shift in guidance and perception. In November 2025, the FDA removed the "black box" warning from menopause hormone therapy products, a change that applied broadly to systemic therapy like patches and pills, not just vaginal estrogen. That has made both patients and providers more comfortable with hormone therapy. Women are also staying on treatment longer than older guidelines recommended, which means more people going back for refills rather than cycling off after a few years.

On the supply side, the manufacturers have not publicly detailed a specific cause. Pharmacy groups and reporting attribute the shortage mainly to demand outpacing production rather than to a confirmed manufacturing or ingredient failure. Availability has also been uneven from one product to the next: per ASHP (the American Society of Health-System Pharmacists), some strengths have been on allocation while others have been on back order with no estimated release date, and those statuses change frequently. The twice-weekly patch, one of the most commonly prescribed forms, appears to have been hit hardest. It's used both for hot flashes and night sweats and for bone protection, which is part of why the disruption has felt so widespread. Once-weekly options, such as Climara, have generally been more available, though that too can vary by dose and location.

How long will the shortage last? There's no confirmed end date. Early manufacturer resupply estimates were near-term, but demand remains high, and reporting suggests availability could stay tight for a while. Because recovery is likely to be uneven across doses and brands, a substitution that works today doesn't guarantee the same product will be on the shelf at your next refill.

What should you do if your estrogen patch is unavailable?

Before you do anything else: don't stop hormone therapy abruptly without talking to your prescriber, and don't assume the shortage means you're out of options. A few concrete steps:

1. Call your pharmacy first, then try others. Availability is inconsistent by brand, dose, and location — a patch that's backordered at one pharmacy may be in stock at another, or under a different manufacturer's label for the same dose.
2. Ask your prescriber about a different patch brand or dose at the same total dose. Not every brand is affected equally, and a therapeutically equivalent product may be available even when your specific one isn't.
3. Ask whether a different delivery method makes sense for you right now. Oral estradiol, gels, and sprays are also options that some providers use as a bridge or ongoing alternative when patches aren't available. This is a conversation to have with your provider, not a swap to make on your own — different formulations are absorbed differently, and switching can change how much estrogen you're actually getting day to day. If your provider recommends switching delivery methods, our comparison of estradiol pills, patches, creams, and gels explains how absorption and dosing differ across each form.
4. If you're also taking progesterone, ask your prescriber how to handle it if your estrogen supply is interrupted or your dose changes. Don't change either medication without their guidance, since progesterone protocols are often calibrated to your estrogen level.
5. Check manufacturer patient assistance programs and 90-day mail-order fills if your pharmacy can access wider distribution channels than a local retail location.

If you switch formulations, what should you watch for?

This is the part that gets skipped in a lot of shortage coverage: switching products because of a supply issue is still a treatment change, and treatment changes don't always feel neutral.

Different estradiol formulations aren't absorbed identically. Pills pass through the liver first. Patches, gels, and creams deliver estrogen through the skin, but at different rates and with different consistency depending on your skin, the application site, and the product design. Even when your provider switches you to an intended equivalent dose, a different delivery method may not feel identical. That's why some women feel fine after switching, and others notice a shift in symptoms like hot flashes, sleep, or mood within the first couple of weeks, even though the prescription's intent didn't change.

Symptoms matter, but they may not tell you right away whether a substitution is affecting you differently. If you do make a switch, it can help to track the change systematically. Our guide to how to know whether a hormone treatment is working walks through what to compare before and after, so you can evaluate the change with more than memory alone.

How to track whether a new formulation is working?

If a shortage pushes you into a formulation you didn't choose, you won't know right away whether it's working the same way as your previous one. This is where daily hormone data can shorten the feedback loop. Oova's longitudinal hormone tracking shows how your estrogen pattern changes over time rather than relying on a single snapshot, so if a new patch, dose, or delivery method is behaving differently than your previous prescription, you have objective data to bring to your provider instead of only a sense that "something feels off." That can be especially useful during a supply disruption, when you may try more than one substitution before things stabilize.

If you specifically suspect your replacement dose isn't giving you the same symptom control, our piece on how to know if your HRT dose is right covers the signs to watch for.

The bottom line

The estrogen patch shortage is real in the way that matters most, which is that women are struggling to fill prescriptions they depend on, even if the FDA hasn't formally classified it. It has hit twice-weekly patches hardest, availability is uneven across brands and doses, and there's no confirmed end date. But a shortage doesn't mean you have to go without treatment. It means the conversation with your pharmacist and provider needs to happen sooner rather than later, and any formulation switch is worth watching closely rather than assuming it's a like-for-like swap. If you can, have that conversation with a menopause-informed provider who can tailor the alternative to your symptoms, your history, and what's actually in stock.

FAQ Section

Is there an estrogen patch shortage right now? 

Yes, in practical terms. Pharmacists (through ASHP) list estradiol patches as in short supply, and women are reporting real difficulty filling prescriptions, with twice-weekly patches such as Vivelle-Dot and its generics hit hardest. The FDA has not added the patch to its official shortage list, because by its criteria supply has technically kept up, so you may see conflicting statements about whether a "shortage" officially exists.

Why are estradiol patches out of stock? 

Mostly rising demand outpacing production. Prescriptions have climbed sharply since the FDA removed its boxed warning on menopause hormone therapy in November 2025, and more women are staying on treatment longer. Manufacturers haven't publicly detailed a specific supply-side cause.

What should I do if my estrogen patch is unavailable? 

Contact your pharmacist to check other locations or manufacturers, and talk to your prescriber about an alternative brand, dose, or delivery method. Once-weekly patches have often been more available than twice-weekly ones. Don't stop treatment abruptly without medical guidance.

Can I switch estrogen patch brands? 

Often yes, if your provider confirms an equivalent dose is available. Not all brands are affected equally by the shortage.Often yes, if your provider confirms an equivalent dose is available. Not all brands are affected equally by the shortage.

Can I switch from an estrogen patch to gel or pills? 

This is a decision to make with your provider, since absorption and dosing equivalence differ by formulation. It's a reasonable option to discuss if your usual patch isn't available.

Should I stop progesterone if I run out of estrogen patches? 

Not without talking to your provider first. Progesterone protocols are often calibrated to your estrogen dose, so a change on one side may need an adjustment on the other.

How can I track whether a new HRT formulation is working? 

Longitudinal hormone tracking can show how your estrogen pattern changes under the new formulation compared to your previous one, giving you and your provider objective data rather than relying on symptoms alone to catch a problem.